Susanne Rautiainen1, I-Min Lee1, Pamela M Rist1, J Michael Gaziano1, JoAnn E Manson1, Julie E Buring1, Howard D Sesso1. 1. From the Department of Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (SR); the Divisions of Preventive Medicine (SR, I-ML, PMR, JMG, JEM, JEB, and HDS) and Aging (JMG and HDS), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA); the Departments of Social and Behavioral Science (PMR) and Epidemiology (I-ML, PMR, JEM, JEB, and HDS), Harvard School of Public Health, Boston, MA; and the VA Boston Healthcare System, Boston, MA (JMG).
Abstract
BACKGROUND: Although multivitamins are widely used, there are limited prospective studies investigating their association with both long- and short-term risk of cardiovascular disease (CVD). OBJECTIVE: The objective was to investigate how multivitamin use is associated with the long- and short-term risk of CVD. DESIGN: A prospective cohort study was conducted of 37,193 women from the Women's Health Study aged ≥45 y and free of CVD and cancer at baseline who were followed for an average of 16.2 y. At baseline, women self-reported a wide range of lifestyle, clinical, and dietary factors. Women were categorized into 1) no current use and 2) current use of multivitamins. Duration and updated measures over the course of the follow-up to address short-term effects were also considered. Women were followed for major CVD events, including myocardial infarction (MI), stroke, and CVD death. RESULTS: During the follow-up, 1493 incident cases of CVD [defined as myocardial infarction (MI), stroke, and CVD death] occurred. In multivariable analyses, multivitamin use compared with no use was not associated with major CVD events (HR: 1.01; 95% CI: 0.89, 1.15), MI (HR: 1.04; 95% CI: 0.84, 1.27), stroke (HR: 0.99; 95% CI: 0.83, 1.18), or CVD death (HR: 1.10; 95% CI: 0.84, 1.45). A nonsignificant inverse association was observed between baseline multivitamin use and major CVD events among women aged ≥70 y (P-interaction = 0.04) and those consuming <3 servings/d of fruit and vegetables (P-interaction = 0.01). When updating information on multivitamin use during the course of follow-up, no associations were observed for major CVD events (HR: 0.91; 95% CI: 0.82, 1.02), MI (HR: 0.89; 95% CI: 0.74, 1.06), stroke (HR: 0.91; 95% CI: 0.78, 1.06), and CVD death (HR: 0.91; 95% CI: 0.71, 1.16). CONCLUSIONS: In this study of middle-aged and elderly women, neither baseline nor time-varying multivitamin use was associated with the long-term risk of major CVD events, MI, stroke, cardiac revascularizations, or CVD death. Additional studies are needed to clarify the role of multivitamins on CVD.
RCT Entities:
BACKGROUND: Although multivitamins are widely used, there are limited prospective studies investigating their association with both long- and short-term risk of cardiovascular disease (CVD). OBJECTIVE: The objective was to investigate how multivitamin use is associated with the long- and short-term risk of CVD. DESIGN: A prospective cohort study was conducted of 37,193 women from the Women's Health Study aged ≥45 y and free of CVD and cancer at baseline who were followed for an average of 16.2 y. At baseline, women self-reported a wide range of lifestyle, clinical, and dietary factors. Women were categorized into 1) no current use and 2) current use of multivitamins. Duration and updated measures over the course of the follow-up to address short-term effects were also considered. Women were followed for major CVD events, including myocardial infarction (MI), stroke, and CVD death. RESULTS: During the follow-up, 1493 incident cases of CVD [defined as myocardial infarction (MI), stroke, and CVD death] occurred. In multivariable analyses, multivitamin use compared with no use was not associated with major CVD events (HR: 1.01; 95% CI: 0.89, 1.15), MI (HR: 1.04; 95% CI: 0.84, 1.27), stroke (HR: 0.99; 95% CI: 0.83, 1.18), or CVD death (HR: 1.10; 95% CI: 0.84, 1.45). A nonsignificant inverse association was observed between baseline multivitamin use and major CVD events among women aged ≥70 y (P-interaction = 0.04) and those consuming <3 servings/d of fruit and vegetables (P-interaction = 0.01). When updating information on multivitamin use during the course of follow-up, no associations were observed for major CVD events (HR: 0.91; 95% CI: 0.82, 1.02), MI (HR: 0.89; 95% CI: 0.74, 1.06), stroke (HR: 0.91; 95% CI: 0.78, 1.06), and CVD death (HR: 0.91; 95% CI: 0.71, 1.16). CONCLUSIONS: In this study of middle-aged and elderly women, neither baseline nor time-varying multivitamin use was associated with the long-term risk of major CVD events, MI, stroke, cardiac revascularizations, or CVD death. Additional studies are needed to clarify the role of multivitamins on CVD.
Authors: Regan L Bailey; Jaime J Gahche; Cindy V Lentino; Johanna T Dwyer; Jody S Engel; Paul R Thomas; Joseph M Betz; Christopher T Sempos; Mary Frances Picciano Journal: J Nutr Date: 2010-12-22 Impact factor: 4.798
Authors: Song-Yi Park; Suzanne P Murphy; Lynne R Wilkens; Brian E Henderson; Laurence N Kolonel Journal: Am J Epidemiol Date: 2011-02-22 Impact factor: 4.897
Authors: Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano Journal: JAMA Date: 2008-11-09 Impact factor: 56.272
Authors: Marian L Neuhouser; Sylvia Wassertheil-Smoller; Cynthia Thomson; Aaron Aragaki; Garnet L Anderson; JoAnn E Manson; Ruth E Patterson; Thomas E Rohan; Linda van Horn; James M Shikany; Asha Thomas; Andrea LaCroix; Ross L Prentice Journal: Arch Intern Med Date: 2009-02-09
Authors: Susanne Rautiainen; Lu Wang; I-Min Lee; JoAnn E Manson; J Michael Gaziano; Julie E Buring; Howard D Sesso Journal: J Hypertens Date: 2016-08 Impact factor: 4.844
Authors: Susanne Rautiainen; J Michael Gaziano; William G Christen; Vadim Bubes; Gregory Kotler; Robert J Glynn; JoAnn E Manson; Julie E Buring; Howard D Sesso Journal: JAMA Cardiol Date: 2017-06-01 Impact factor: 14.676
Authors: Pamela M Rist; Howard D Sesso; Lisa G Johnson; Aaron K Aragaki; Lu Wang; Susanne Rautiainen; Aditi Hazra; Deirdre K Tobias; Meryl S LeBoff; Hagen Schroeter; Georgina Friedenberg; Trisha Copeland; Allison Clar; Lesley F Tinker; Rebecca P Hunt; Shari S Bassuk; Ara Sarkissian; Douglas C Smith; Eduardo Pereira; William R Carrick; Emily S Wion; Jennifer Schoenberg; Garnet L Anderson; JoAnn E Manson Journal: Contemp Clin Trials Date: 2022-03-12 Impact factor: 2.261
Authors: Susanne Rautiainen; Pamela M Rist; Robert J Glynn; Julie E Buring; J Michael Gaziano; Howard D Sesso Journal: J Nutr Date: 2016-04-27 Impact factor: 4.798
Authors: Carmen de la Fuente-Arrillaga; Itziar Zazpe; Susana Santiago; Maira Bes-Rastrollo; Miguel Ruiz-Canela; Alfredo Gea; Miguel Angel Martinez-Gonzalez Journal: BMC Public Health Date: 2016-03-01 Impact factor: 3.295